StemRad Overview

  • Founded
  • 2011
  • Status
  • Private
  • Employees
  • 21
  • Latest Deal Type
  • Series C1
  • Investors
  • 5

StemRad General Information


Developer of a wearable technology designed to protect the human body from high doses of radiation. The company's wearable vest specializes in protecting stem cells in the body's largest reservoir of bone marrow and features a highly complex design based on knowledge of radiation's effects and body composition, protection while maintaining full mobility, optimal hip and shoulder distribution for support, comfort and mobility, fire-resistant and durability and reflector strips and ballistic resistance, enabling wearer with the mobility required to perform life-saving tasks in the event of a nuclear catastrophe and thus protect himself from harmful gamma radiation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Aerospace and Defense
Other Commercial Products
Primary Office
  • 4 Raoul Wallenberg Street
  • Tel Aviv 6971905
  • Israel
+972 00-000-0000

StemRad Timeline

Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

StemRad Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Seed Round 04-Mar-2021 000 Completed Generating Revenue
4. Grant 01-Jun-2019 00000 000 Completed Generating Revenue
3. Later Stage VC (Series C) 01-Dec-2017 000 000 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2017 Completed Startup
1. Early Stage VC (Series B) 01-Jan-2016 Completed Startup
To view StemRad’s complete valuation and funding history, request access »

StemRad Executive Team (7)

Name Title Board Seat Contact Info
Oren Milstein Ph.D Co-Founder, Chief Executive Officer, Board Member & Chief Scientific Officer
Shahar Omri Chief Financial Officer
Gideon Waterman Ph.D Chief Technology Officer
Alan Panzer Chief Commercial Officer
Bruce Zwiebel Chief Medical Officer
You’re viewing 5 of 7 executive team members. Get the full list »

StemRad Board Members (5)

Name Representing Role Since
Alex Gurevich Ph.D StemRad Board Member 000 0000
Daniel Levitt Self Co-Founder, Board Member & President 000 0000
Jeffrey Vinik Self Board Member 000 0000
Ronen Melnik Self Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

StemRad Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

StemRad Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Kirenaga Venture Capital Minority 000 0000 000000 0
Space Florida Government 000 0000 000000 0
Jeffrey Vinik Angel (individual) Minority 000 0000 000000 0
Florida-Israel Business Accelerator Accelerator/Incubator Minority 000 0000 000000 0
Wanaka Capital Partners Venture Capital Minority 000 0000 000000 0
To view StemRad’s complete investors history, request access »